News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
664,862 Results
Type
Article (56550)
Company Profile (86)
Press Release (608226)
Section
Business (181277)
Career Advice (2841)
Deals (34220)
Drug Delivery (109)
Drug Development (77999)
Employer Resources (165)
FDA (15880)
Job Trends (14755)
News (319117)
Policy (32494)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
Academia (2717)
Academic (2)
Accelerated approval (3)
Adcomms (22)
Allergies (83)
Alliances (45385)
ALS (86)
Alzheimer's disease (1312)
Antibody-drug conjugate (ADC) (99)
Approvals (15886)
Artificial intelligence (241)
Autoimmune disease (17)
Automation (14)
Bankruptcy (321)
Best Places to Work (11405)
BIOSECURE Act (15)
Biosimilars (106)
Biotechnology (56)
Bladder cancer (62)
Brain cancer (25)
Breast cancer (254)
Cancer (1970)
Cardiovascular disease (154)
Career advice (2394)
Career pathing (32)
CAR-T (148)
Cell therapy (404)
Cervical cancer (20)
Clinical research (63385)
Collaboration (742)
Compensation (362)
Complete response letters (20)
COVID-19 (2593)
CRISPR (39)
C-suite (227)
Cystic fibrosis (99)
Data (1918)
Decentralized trials (2)
Denatured (26)
Depression (40)
Diabetes (238)
Diagnostics (6349)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (42)
Drug discovery (111)
Drug pricing (108)
Drug shortages (24)
Duchenne muscular dystrophy (77)
Earnings (64365)
Editorial (35)
Employer branding (20)
Employer resources (144)
Events (97337)
Executive appointments (671)
FDA (17004)
Featured Employer (29)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (696)
Gene editing (100)
Generative AI (21)
Gene therapy (272)
GLP-1 (659)
Government (4755)
Grass and pollen (4)
Guidances (45)
Healthcare (19049)
Huntington's disease (18)
IgA nephropathy (19)
Immunology and inflammation (105)
Indications (27)
Infectious disease (2720)
Inflammatory bowel disease (133)
Inflation Reduction Act (10)
Influenza (48)
Intellectual property (87)
Interviews (546)
IPO (15737)
IRA (41)
Job creations (3748)
Job search strategy (2009)
Kidney cancer (9)
Labor market (29)
Layoffs (505)
Leadership (18)
Legal (7905)
Liver cancer (69)
Lung cancer (281)
Lymphoma (128)
Machine learning (4)
Management (57)
Manufacturing (258)
MASH (56)
Medical device (13171)
Medtech (13176)
Mergers & acquisitions (19003)
Metabolic disorders (594)
Multiple sclerosis (68)
NASH (15)
Neurodegenerative disease (74)
Neuropsychiatric disorders (23)
Neuroscience (1779)
NextGen: Class of 2025 (6687)
Non-profit (4561)
Northern California (2242)
Now hiring (20)
Obesity (311)
Opinion (233)
Ovarian cancer (70)
Pain (82)
Pancreatic cancer (74)
Parkinson's disease (126)
Partnered (20)
Patents (206)
Patient recruitment (95)
Peanut (50)
People (59523)
Pharmaceutical (26)
Pharmacy benefit managers (20)
Phase I (19724)
Phase II (27915)
Phase III (20758)
Pipeline (992)
Podcasts (60)
Policy (110)
Postmarket research (2479)
Preclinical (8163)
Press Release (67)
Prostate cancer (95)
Psychedelics (30)
Radiopharmaceuticals (250)
Rare diseases (347)
Real estate (6216)
Recruiting (67)
Regulatory (21835)
Reports (37)
Research institute (2367)
Resumes & cover letters (431)
Rett syndrome (3)
RNA editing (3)
RSV (37)
Schizophrenia (66)
Series A (121)
Series B (80)
Service/supplier (10)
Sickle cell disease (52)
Southern California (1985)
Special edition (15)
Spinal muscular atrophy (152)
Sponsored (27)
Startups (3375)
State (1)
Stomach cancer (9)
Supply chain (54)
The Weekly (31)
United States (19931)
Vaccines (674)
Venture capitalists (31)
Webinars (12)
Weight loss (204)
Women's health (32)
Worklife (17)
Date
Today (227)
Last 7 days (709)
Last 30 days (2683)
Last 365 days (32158)
2025 (7783)
2024 (33424)
2023 (37758)
2022 (48457)
2021 (53552)
2020 (52784)
2019 (46650)
2018 (35524)
2017 (31824)
2016 (31197)
2015 (36544)
2014 (29456)
2013 (25644)
2012 (27089)
2011 (27480)
2010 (25607)
Location
Africa (909)
Alabama (51)
Alaska (7)
Arizona (174)
Arkansas (13)
Asia (39317)
Australia (6912)
California (5146)
Canada (1742)
China (456)
Colorado (236)
Connecticut (258)
Delaware (125)
Europe (89557)
Florida (781)
Georgia (188)
Idaho (57)
Illinois (516)
India (25)
Indiana (272)
Iowa (7)
Japan (133)
Kansas (102)
Kentucky (24)
Louisiana (7)
Maine (59)
Maryland (799)
Massachusetts (3751)
Michigan (210)
Minnesota (328)
Mississippi (2)
Missouri (80)
Montana (30)
Nebraska (22)
Nevada (55)
New Hampshire (62)
New Jersey (1525)
New Mexico (30)
New York (1502)
North Carolina (923)
North Dakota (8)
Northern California (2242)
Ohio (184)
Oklahoma (15)
Oregon (34)
Pennsylvania (1155)
Puerto Rico (10)
Rhode Island (23)
South America (1241)
South Carolina (15)
South Dakota (1)
Southern California (1985)
Tennessee (93)
Texas (783)
Utah (165)
Virginia (127)
Washington D.C. (54)
Washington State (480)
West Virginia (3)
Wisconsin (53)
664,862 Results for "united states department of agriculture usda".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States
Yield10 Bioscience, Inc., an agricultural bioscience company, announced that USDA-APHIS’s Biotechnology Regulatory Services has determined that Yield10’s glufosinate tolerant Camelina sativa may be grown and bred in the United States.
November 15, 2023
·
6 min read
Genetown
USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States
Yield10 Bioscience, Inc. announced that USDA-APHIS’s Biotechnology Regulatory Services has determined that Yield10’s Camelina sativa varieties developed using genetic engineering to produce omega-3 fatty acids are not subject to the regulations under 7 CFR part 340, and may be grown and bred in the United States.
March 21, 2024
·
6 min read
Genetown
USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States-Herbicide Technology Critical to Enabling Large-Acreage Adoption of Camelina in North America
Yield10 Bioscience, Inc., an agricultural bioscience company, announced that the U.S. Department of Agriculture Animal & Plant Health Inspection Service’s Biotechnology Regulatory Services has determined that Yield10’s stacked herbicide tolerant Camelina sativa may be grown and bred in the United States.
November 15, 2023
·
5 min read
Press Releases
Ryoncil® is Now Available for Purchase in the United States
March 27, 2025
·
6 min read
Press Releases
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
February 17, 2025
·
3 min read
Policy
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced the U.S. Department of Agriculture approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza.
June 25, 2024
·
6 min read
Press Releases
American Liver Foundation and the United States Department of Veterans Affairs and Veteran Health Administration Partner to help Veterans at risk or living with Liver Disease
January 23, 2025
·
5 min read
BioMidwest
USDA Awards bioMérieux GENE-UP® CAMPLYLOBACTER as Method of Choice for Campylobacter Detection in USDA Food Safety and Inspection Service Laboratories
bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the incorporation of the company’s GENE-UP® CAMPYLOBACTER assay into the methodology used by the USDA-FSIS Field Service Laboratories.
June 11, 2024
·
3 min read
Policy
EPA, FDA, and USDA Issue Joint Regulatory Plan for Biotechnology
In response to President Biden’s Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” the U.S. Environmental Protection Agency, the U.S. Food and Drug Administration, and the U.S. Department of Agriculture have developed a plan to update, streamline, and clarify their regulations and oversight mechanisms for products of biotechnology.
May 8, 2024
·
3 min read
Policy
FDA, USDA, EPA Enhance Efforts to Reduce Food Loss and Waste; Welcome USAID to Interagency Collaborative
The U.S. Food and Drug Administration announced the signing of a formal agreement with the U.S. Department of Agriculture and the U.S. Environmental Protection Agency to renew their Federal Interagency Collaboration to Reduce Food Loss and Waste.
May 30, 2024
·
4 min read
1 of 66,487
Next